National Cancer Institute; Notice of Charter Renewal, 55306 [2020-19619]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
55306
Federal Register / Vol. 85, No. 173 / Friday, September 4, 2020 / Notices
per diem and travel expenses incurred
for attending Committee meetings and/
or conducting other business on behalf
of the Committee, as authorized by
section 5 U.S.C. 5703 for persons
employed intermittently in government
service. Members who are already
officers or employees of the United
States Government shall not receive
additional compensation for service on
the Committee, but receive per diem
and travel expenses incurred for
attending Committee meetings and/or
conducting other business on behalf of
the Committee.
The following information must be
included in the package of materials
submitted for each individual being
nominated for consideration: (1) A
statement that includes the name and
affiliation of the nominee and a clear
statement regarding the basis for the
nomination, including the area(s) of
demonstrated expertise or concern that
may support eligibility of a nominee for
service on the Committee, as described
above; (2) confirmation the nominee is
willing to serve as a member of the
Committee; (3) the nominee’s contact
information (please include home
address, work address, daytime
telephone number, and an email
address); and (4) a current copy of the
nominee’s curriculum vitae.
Nomination packages may be submitted
directly by the individual being
nominated or by the person/
organization recommending the
candidate.
HHS will endeavor to ensure that the
membership of the Committee is fairly
balanced in terms of points of view
represented and that individuals from a
broad representation of geographic
areas, gender, ethnic and minority
groups, as well as individuals with
disabilities, are considered for
membership. Appointments shall be
made without discrimination on the
basis of age, race, color, national origin,
sex, disability, or religion.
Individuals who are selected to be
considered for appointment will be
required to provide detailed information
regarding their financial holdings,
consultancies, and research grants or
contracts. Disclosure of this information
is required in order for HRSA to
determine if the selected candidate is
involved in any activity that may pose
a potential conflict of interest with the
official duties to be performed as a
member of the Committee and to
identify any required remedial action
needed to address the potential conflict.
Authority: The ACHDNC was established
under the Public Health Service (PHS) Act,
42 U.S.C. 217a: Advisory councils or
VerDate Sep<11>2014
16:42 Sep 03, 2020
Jkt 250001
committees and Title XI § 1111(g) (42 U.S.C.
300b–10(g)).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Maria G. Button,
Director, Executive Secretariat.
National Institutes of Health
[FR Doc. 2020–19631 Filed 9–3–20; 8:45 am]
National Cancer Institute; Notice of
Charter Renewal
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Promoting the Rule of Law Through
Improved Agency Guidance
Documents
Office of the Secretary,
Department of Health and Human
Services.
AGENCY:
ACTION:
Notice.
On October 9, 2019, the
President issued Executive Order (E.O.)
13891: Promoting the Rule of Law
Through Improved Agency Guidance
Document. This E.O. requires all
Federal Agencies to establish an on-line
guidance portal and to rescind any
guidance documents that are no longer
active or valid.
SUMMARY:
The
Department of Health and Human
Services is updating its Notice
published on July 2, 2020 regarding
Executive Order 13891. In that Notice,
HHS made available its guidance portal
which included all active guidance
documents across HHS’s 27 Operating
and Staff Divisions. That Notice brought
awareness that while many of the
Centers for Medicare and Medicaid’s
(CMS) active guidance documents were
included, it was not reflective of CMS’s
full inventory. OMB had granted CMS
an extension until July 31, 2020 to fully
populate the database to reflect CMS’s
full inventory of active guidance
documents.
This Notice informs of an additional
OMB extension granted to the Centers
for Medicare and Medicaid (CMS) until
September 30, 2020 to fully populate all
of its inventory of active guidance
documents.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
Samuel Shipley, Executive Secretariat,
at Guidance@hhs.gov or (202) 690–5627.
Wilma M. Robinson,
Deputy Executive Secretary, Department of
Health and Human Services.
[FR Doc. 2020–19568 Filed 9–3–20; 8:45 am]
BILLING CODE 4150–03–P
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the Charter for the National
Cancer Institute Council of Research
Advocates was renewed for an
additional two-year period on August
17, 2020.
It is determined that the National
Cancer Institute Council of Research
Advocates is in the public interest in
connection with the performance of
duties imposed on the National Cancer
Institute and National Institutes of
Health by law, and that these duties can
best be performed through the advice
and counsel of this group.
Inquiries may be directed to Claire
Harris, Acting Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail Stop Code 4875), harriscl@nih.gov
or Telephone (301) 496–2123.
Dated: September 1, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–19619 Filed 9–3–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–17–
144: Limited Competition: National Primate
Research Centers (P51).
E:\FR\FM\04SEN1.SGM
04SEN1
]]>Agencies
[Federal Register Volume 85, Number 173 (Friday, September 4, 2020)]
[Notices]
[Page 55306]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19619]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Charter Renewal
In accordance with Title 41 of the U.S. Code of Federal
Regulations, Section 102-3.65(a), notice is hereby given that the
Charter for the National Cancer Institute Council of Research Advocates
was renewed for an additional two-year period on August 17, 2020.
It is determined that the National Cancer Institute Council of
Research Advocates is in the public interest in connection with the
performance of duties imposed on the National Cancer Institute and
National Institutes of Health by law, and that these duties can best be
performed through the advice and counsel of this group.
Inquiries may be directed to Claire Harris, Acting Director, Office
of Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail Stop Code 4875), [email protected] or Telephone
(301) 496-2123.
Dated: September 1, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-19619 Filed 9-3-20; 8:45 am]
BILLING CODE 4140-01-P
